NEW YORK (GenomeWeb News) – Sequenom said this week that University of Michigan researchers conducted a study that showed that the firm's MassArray technology can identify human papillomavirus infections in women who previously tested negative with the Qiagen Hybrid Capture 2 test.

According to the firm, its PCR-MS method detected the presence of high-risk HPV in 46.7 percent of women who had tested negative by Hybrid Capture 2. The study is scheduled to appear in the September 2009 edition of the Journal of Virological Methods.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.